Results 141 to 150 of about 54,528 (266)

PREVALENCE AND SPECTRUM OF DIABETIC PERIPHERAL NEUROPATHY AND ITS CORRELATION WITH INSULINRESISTANCE - AN EXPERIENCE FROM EASTERN INDIA

, 2023
Manidipa Majumdar, Mainak Banerjee, Jinesh Sengupta, Chanchal Kr. Jana, Biman Kanti Roy   +4 more
openalex   +1 more source

Efficacy and safety of switching basal insulin to insulin glargine 300 U/mL in individuals with inadequately controlled type 2 diabetes on advanced insulin therapies: The Toujeo‐Neo T2DM study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This real‐world study evaluated the effectiveness and safety of switching basal insulin (BI) to insulin glargine 300 U/mL (Gla‐300) in adults with inadequately controlled type 2 diabetes mellitus (T2DM), previously receiving basal‐supported oral therapy plus prandial insulin (BOTplus) or multiple (≥3) daily injections (MDI) of short ...
Stefan Pscherer, Andreas Fritsche, Helmut Anderten, Katrin Pegelow, Henry Y. Han, Martin Pfohl, Jochen Seufert   +6 more
wiley   +1 more source

Metabolomics and Gut Microbiota in Elderly Patients with Diabetic Peripheral Neuropathy and Sarcopenia. [PDF]

Diabetes Metab Syndr Obes
Wang X, Yu F, Cai Q, Li B, Li X, Fu C, Yu X, Yin W, Zeng S, Gao H, Cheng M.   +10 more
europepmc   +1 more source

Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Insulin icodec, the first once‐weekly basal insulin analogue, was approved in China in 2024. Although it has demonstrated robust clinical efficacy, its budget impact remains unknown, and the long‐term cost‐utility within the reimbursement context needs further estimates.
Xichen Tong, Yawen Zhang, Lei Zhang, Luying Zhang   +3 more
wiley   +1 more source

Machine learning in the prediction of diabetic peripheral neuropathy: a systematic review. [PDF]

BMC Med Inform Decis Mak
Ma Y, Wang Z, Yao Z, Lu B, He Y.
europepmc   +1 more source

Relationship Between Fasting C-Peptide to Diabetes Duration Ratio (FCP/DD) and Diabetic Peripheral Neuropathy

Yueyue Fu, Yuling Xing, Linlin Yang, Jing Liu, Huijuan Ma   +4 more
openalex   +2 more sources

Non-coding RNAs in diabetic peripheral neuropathy: their role and mechanisms underlying their effects [PDF]

Yiqian He, Ling Qu
openalex   +1 more source

A systematic review of glucocorticoid use in type 1 diabetes: Glycaemic effects and clinical management strategies

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Glucocorticoids (GCs) are widely utilised for the treatment of inflammatory and autoimmune conditions but often precipitate significant hyperglycaemia. People with type 1 diabetes (PWT1D) may be particularly affected due to the challenges of adjusting insulin dosing, for which recommendations remain unclear.
Alexandra Katz, Aidan Shulkin, Asmaa Housni, Amélie Roy‐Fleming, Rémi Rabasa‐Lhoret, Jean‐Francois Yale, Michael A. Tsoukas, Tricia M. Peters, Anne‐Sophie Brazeau   +8 more
wiley   +1 more source

SUN-279 Peripheral Neuropathy in an Adolescent following Severe Diabetic Ketoacidosis: A Case Study with Review of the Literature

, 2019
Alison Christy, Angela S. Lennon
openalex   +1 more source

Association between daily steps, diabetes management and health indicators in people living with type 1 diabetes: A cross‐sectional study from the BETTER registry

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims In people with type 1 diabetes, physical activity provides important health benefits but is mainly limited by fear of hypoglycaemia. Daily step count is a simple indicator of ambulatory activity. This study examined associations between step count and health indicators.
Thélo I. Garré, Capucine G. Guédet, Laure Alexandre‐Heymann, Virginie Messier, Valérie Boudreau, Semah Tagougui, Claude Laforest, Anne‐Sophie Brazeau, Rémi Rabasa‐Lhoret, Jane E. Yardley   +9 more
wiley   +1 more source